ETFIQData as of Nov 19, 2026. · etfiq.com/funds/smri

SMRI Fact Sheet: Bushido Capital US Equity ETF

Share
$43.20
close, Nov 20, 2026

Over the year to Nov 19, 2026, SMRI returned +29.8% in total and charged 0.71% a year.

1-year total return
+28.6%
IVE +13.9% to Nov 20, 2026
Expense ratio
0.71%
a year
Net flow, 12 months to Jul 31, 2026
+$43.7m
monthly N-PORT basis to Jul 31, 2026

Growth of $10,000, 1 year

SMRI $12,977 +29.8% · IVE $11,445 +14.4% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−8.9%
3 months−10.4%
Year to date+21.0%
1 year+28.6%
3 years+79.7%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
Tenet Healthcare Corp2.57%
Workday Inc2.52%
Accenture PLC2.38%
Veeva Systems Inc2.33%
Valero Energy Corp2.33%
Marathon Petroleum Corp2.32%
Adobe Inc2.31%
Phillips 662.25%
Intuit Inc2.23%
Expedia Group Inc2.21%

SMRI top ten by weight, 23.4% of the fund, of its 50 equity positions, from the holdings filed for Jul 31, 2026.

Facts

Equity fund · Actively managed · First traded Sep 14, 2023 · Benchmark S&P 500 Value Index, measured by IVE, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, SMRI Fact Sheet: Bushido Capital US Equity ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/smri/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/smri.